Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Startups channel feed
Roche vet Jean-Jacques Garaud woos international believers in his French startup's take on septic shock
6 years ago
Financing
Struggling poo-testing startup uBiome files for bankruptcy, months after FBI kicks off investigation
6 years ago
FDA+
Versant-backed precision oncology startup Repare Therapeutics scores $82M+ in latest round
6 years ago
Financing
Nkarta maps out clinical, manufacturing plans for CAR-NK following $114M round led by Samsara
6 years ago
Financing
Cell/Gene Tx
RA Capital-backed cell therapy player in the neoantigen game grabs a $121M megaround to fund first human studies
6 years ago
Financing
Versant-backed Chinook gets a $65M launch round for its discovery quest in a resurgent kidney field
6 years ago
Discovery
Finch grabs a $53M round designed to take their ‘breakthrough’ microbiome treatment through a potentially pivotal trial
6 years ago
FDA+
Johns Hopkins scientists raise $137M megaround for a trio of spinouts looking to tackle Alzheimer’s, Parkinson’s and fibrosis
6 years ago
Financing
Biotech targeting rare heart mutation with gene therapy scores $11M in Series A haul
6 years ago
Financing
R&D
IBD startup Landos lands $60M Series B in first test case of Chris Garabedian's lean and mean model at Xontogeny
6 years ago
Financing
Alexandria seals $143M deal in Seattle's 'heart of the heart,' grabbing coveted land to build its biotech cluster
6 years ago
Part procedure, part drug: Robert Ang joins Siddhartha Mukherjee in pioneering a new type of cell engineering
6 years ago
People
Cell/Gene Tx
Biotech startup joins quest to harness microbiome to untether reliance on antibiotics in women's health
6 years ago
Backed by Novo and OrbiMed, Thierry Abribat hauls in $75M for biotech #3 — a transatlantic upstart focused on rare diseases
6 years ago
People
Laser-focused on colorectal cancer test, Freenome wins $160M from marquee VC pack led by RA, Polaris
6 years ago
Financing
Novartis backs Harvard spinout's quest to build TCR repository in $48M round
6 years ago
Financing
Chardan's blank check company picks microbiome player BiomX for $70M reverse merger
6 years ago
Backed by some of the biggest names in biotech, Norbert Bischofberger gets his megaround for platform tech out of MIT
6 years ago
Financing
Bayer, Longwood back star researcher's deep dive into the tumor microenvironment for new I/O targets
6 years ago
Financing
Going inside cells, Sung Joo Lee has sketched some big goals for his small — but global — team of drug hunters
6 years ago
R&D
San Diego ophthalmic biotech upstart raises $28M on alternative to corneal transplant
6 years ago
Financing
Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups
6 years ago
Financing
Can a Medicare Advantage insurer be great at drug development for their target audience?
6 years ago
Medicxi, Taiho infuse €30M into Evotec spinout — eyeing cancer meds targeting DNA damage response pathways
6 years ago
Financing
First page
Previous page
56
57
58
59
60
61
62
Next page
Last page